Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female based on biological sex
- People aged between 18 and 85 years old
- People who have been diagnosed with primary, invasive breast cancer that has not spread to other parts of the body (stages I to III)
- People who finished a specific type of chemotherapy for breast cancer (including anthracycline, alkylating agent, and/or taxane-based treatments) more than 6 months ago but less than 18 months ago
- People currently taking certain other breast cancer treatments — such as hormone therapies, CDK4/6 inhibitors, PARP inhibitors, HER2-targeted therapies, immunotherapy, or bisphosphonates — as these are permitted during the study
- People who have no medical reasons preventing them from exercising or taking part in the study
- People whose case has been approved by the study doctor
Who may not be able to join:
- People who do not meet the inclusion criteria listed above
- People who are scheduled to have surgery or radiation therapy during the period the study intervention takes place
- People with certain heart or blood vessel conditions, including stroke, heart failure, heart attack, angina, coronary artery disease, or who show signs of reduced blood flow to the heart during a supervised exercise test
- People with moderate to severe lymphedema (swelling in the limbs rated at stage 2 or higher) before joining the study
- People who are pregnant
- People currently taking part in another experimental study that could affect the results, such as a weight-loss diet program
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Demetra Christou, PhD, University of Florida
Phone: 352-294-1746
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in brachial FMD; Change in cardiac function (global longitudinal strain); Percent completed vs. planned exercise frequency; Percent completed vs. planned exercise duration; Percent completed vs. planned exercise intensity; Number of participants who experience adverse events as defined by most recent CTCAE throughout the exercise intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.